Moderna MRNA
NASDAQ MRNA
$254.19 +12.73 (+5.27%)
At close: Nov 6, 2026 · 4:00 PM EST

Moderna (MRNA) Debt Ratio (2025 - 2026)

Updated

Moderna's (MRNA) Debt Ratio stood at 0.05 in Q2 2026, up 5.0% from the prior quarter.

Analysis

Moderna (MRNA) Debt Ratio (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 0.33
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 0.23
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 0.55
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 0.41
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -0.10
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 0.56
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 0.51
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 0.31
10 Moderna 100.92 Bn 80.27 Bn 52.00 Mn 0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Mar 31, 2026 0.05
Dec 31, 2025 0.05
API Access

Moderna Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MRNA&period=max&api_key=YOUR_API_KEY